ALS TDI is working with several industry and academic partners to discover new biomarkers for ALS through the ALS Research Collaborative (ARC). Currently, these efforts have led to the development of five prototype digital biomarkers.

Organized by Challenge Works, the Longitude Prize on ALS is a global challenge to develop AI-driven tools that accelerate ALS research. ALS TDI is a data partner, contributing over a decade of clinical and digital data from the ALS Research Collaborative (ARC) Study.

In anticipation of this year’s ALS Walk for Research, we’re interviewing the leaders of some of the event’s biggest and most successful teams. Today, we’re joined by Cory Fanelli of the team Chip Fanelli Fan Club.

At first, Her ALS Story came together and connected with each other primarily online. However, after a small group of HAS members got together at a beer festival in 2021, Kate says that they quickly recognized the uplifting power of meeting in person. Soon, they were discussing the possibility of a larger, multi-day gathering.

The ALS Therapy Development Institute (ALS TDI) is proud to announce that a collection of cells derived from ALS patient-derived induced pluripotent stem cell (iPSC) lines will now be made widely available to researchers around the world.

The ALS Therapy Development Institute (ALS TDI) is pleased to announce its acceptance as a member of DataCite, a leading global organization dedicated to ensuring research is openly available and accessible across scientific disciplines. This partnership will significantly enhance the discoverability, accessibility, and citability of the ALS Research Collaborative (ARC) dataset, a vital resource in the global search for effective ALS treatments.